News > Recent News

Latest news

Flordis proudly sponsors the Swinburne University brain health and natural medicine conference, 6-7th February 2012

We are reminded about the importance of brain health every day in practice as our patients present with mental conditions such as depression, anxiety, stress related illness, insomnia, decline in memory and Attention Deficit Hyperactivity Disorder. As natural medicine practitioners we have many wonderful brain health herbal allies, many of which will be the subject of an upcoming event entitled 'Brain health and natural medicine’. This will to be held on the 6-7th February 2012 at Swinburne University, Melbourne and Flordis is proud to be one of the event sponsors.

Read More
Media Release: Clinically proven natural medicine wins the support of top medicos as new clinical trial progresses

One of Australia’s leading gastroenterologists says he believes that a clinically proven herbal product has its place among, and is probably at least as effective as, more expensive mainstream treatments for common gastrointestinal disorders that impact thousands of Australians.

Read More
Flordis In Focus: Nick Read joins the team

 

Nick has always enjoyed spending time in the garden growing his own fruit, vegetables and herbs and then using these plants as medicine. This passion led him to change career by successfully completing his Advanced Diploma of Western Herbal Medicine. Currently, he is halfway through his Bachelor of Health Science in Complementary Medicine. 

Read More
Flordis/SFI commits to sharpen minds with ABC's Adopt-An-Herb for Bacopa

The adoption of Bacopa monnieri (brahmi) by Flordis/SFI with the American Botanical Council’s Adopt-An-Herb program will ensure up-to-date clinical information on Bacopa monnieri, which will be easily available via HerbMedPro.

Read More
Functional GI Disease: Solving the Therapeutic Dilemma

Iberogast® (STW 5) was the subject of a symposium on “Functional GI Disease: Solving the Therapeutic Dilemma” held as part of the European Bridging Meeting in Gastroenterology in Berlin, Germany. Here Iberogast was recognised as the only phytotherapeutical remedy which fulfills the description of a multi-target product.

Read More
EMEA singles out Premular as the only evidence-based Vitex

 

The European Medicines Agency (EMEA) has granted Premular, specific extract of Vitex agnus-castus (Ze 440) a “well-established use” classification “for the treatment of premenstrual syndrome” based on proof of efficacy and safety.1,2

Read More
The Brahmi Army-KeenMind CDRI 08 delegation sent to India

Banaras Hindu University, Varanasi, India: A Satellite Symposium on ‘Brain Ageing and Dementia: Basic and Translational Aspects’ acted as the platform for the international neuroscience research community to discuss age related dementia and neurodegenerative disorders. The symposium was organised by the Federation of Asian-Oceanian Neuroscience Societies (FAONS) and the Indian Academy of Neurosciences (IAN).

Read More
BMJ makes U-turn statement on glucosamine study

January 2011: the British Medical Journal has released a statement following a Post Publication Review Meeting on the recently published meta-analysis of Wandel et al, which questioned the clinical relevance of the effects of glucosamine (and chondroitin, and their combination) in osteoarthritis.

Read More
Flordis Research Update
The end of the year seems a fitting time to review the ongoing research on 4 of the Flordis specifically clinically proven products. At Flordis, we are committed to bringing you the best evidenced natural products from around the world, which is why to be part of the range, each product has to have an established body of published data. We are also dedicated to encouraging ongoing research for our products and as such, work closely with Australian researchers.
Read More
Current Perspective on glucosamine sulphate as a disease modifying agent in osteoarthritis

On September 23-26, the annual OARSI World Congress on Osteoarthritis was held in Brussels for those involved in osteoarthritis (OA) research and treatment. The congress featured speakers from around the world, presenting wide spectrum of topics related to cartilage and OA.

Read More
Complementary therapy is a blend of gobbledygook, treatments of dubious value and genuinely useful medicines

Peddlers of "natural" potions and pills will be delighted with the finding that complementary medicines ease the pressure on the strained health budget.

The Advertiser, 14th September 2010

Read More
Benefits to all from alternative therapies

Phytodolor (a blend of aspen, ash and goldenrod) could help pain and inflammation for sufferers of osteoarthritis, while acupuncture used alongside standard care could provide "significantly better pain outcomes compared to standard care alone" for the nearly 2 million who experience chronic non-specific lower back pain.

Sydney Morning Herald, The Age and Brisbane Times, 13th September 2010

Read More
Australian study shows Phytodolor could save $178 million in healthcare costs each year

An economic study into the cost effectiveness of complementary medicine in Australia has identified potential savings of $178 million each year if Phytodolor was used in place of non steroidal anti-inflammatory drugs (NSAIDs) for the treatment of osteoarthritis.

Read More
First herbal medicine to have its effectiveness acknowleged by the TGA

For the first time, the Therapeutic Goods Administration (TGA) has evaluated and subsequently registered a herbal medicine product based on its efficacy via the new registration pathway for complementary medicines.

Read More
The Australian launch of the ‘Gold Standard’ in Panax Ginseng – Ginsana® (G115)

A recent survey (IMS 2008) established that malaise and fatigue are the most medically untreated complaints reported by 95.4% of patients.

In answer to the ‘chronically tired’ patient, Flordis has today launched Ginsana (G115), the ‘gold standard’ and most scientifically researched ginseng product in the world.

Read More
Flordis launches “one of the most widely prescribed herbal medicines in the world”1

Just in time for this winter’s cold and flu season, Flordis is launching Sinupret Forte® which is specifically clinically proven to treat the symptoms of sinusitis, sinus pain and mild upper respiratory tract infections.

Read More
Iberogast celebrates its 50th Birthday

Iberogast (STW 5) has celebrated its golden anniversary with a conference in Germany entitled, “50 Years of Iberogast”.

Read More
Introducing Flordis Nutritionals

Today, Flordis has launched a new range called Flordis Nutritionals, which has been formulated by a team of leading integrative medical practitioners with over150 years of combined clinical experience.

Read More
KeenMind (CDRI 08) bringing hope to Alzheimer's patients

KeenMind was covered in an article entitled  "Alzheimer Hope in Ancient 
Medical Memories" that appeared in a supplement inserted in The
 Australian newspaper today (9th Dec 2009). The article covers the 
Australian research conducted at Swinburne University which investigated 
KeenMind's effect on improving memory.

Read More
KeenMind wins ARC Discovery Grant

The Australian Research Council (ARC) has awarded a highly prestigious ARC Discovery Grant to Swinburne University of Technology for research into healthy ageing with the special extract of Bacopa monnieri, KeenMind® (CDRI 08).

Read More
Beat the Bloat

10 Ways to Settle Your Stomach: No. 7 Try a herbal remedy for bloating such as Iberogast. "This is a mixture of nine different herbs that have been scientifically trialled," says Professor Bolin. Body & Soul, Sunday Telegraph, 1/11/09

Read More
Flordis gives support to the establishment of an Australian register of naturopaths and herbalists

Today, Flordis gives its full support to the establishment of an independent steering committee dedicated to forming The Australian Register of Naturopaths and Herbalists (ARONAH).

Read More
World experts on neurocognition unveil the latest evidence-based research at Fapronatura 2009

This week, the enhancement of cognitive abilities through the use of evidence-based herbal medicines will be in the spotlight at the Second International Symposium about Pharmacology of Natural Products (FAPRONATURA 2009).

Read More
Natural alternative targets nicotine addiction in a unique way

On the eve of World No Tobacco Day, leading Australian researcher, Professor Con Stough, calls for natural smoking cessation alternatives to be taken seriously.
 
Professor Stough, Brain Sciences Institute, Swinburne University of Technology, Melbourne has been involved in the world’s first studies of a Hypericum perforatum (Remotiv®, Ze 117) product compared to transdermal Nicotine Replacement Therapy, and the combination of both, in the management of smoking cessation.

Read More
Vitamin D3 joins Flordis Nutritionals

Flordis D3 – 1000 is the latest addition to Flordis Nutritionals. For improved compliance and practicality, Flordis D3 – 1000 is packaged as easy to take tablets providing 3 months supply.

Read More
KeenMind is here!

Flordis are excited to announce the launch of KeenMind – this meticulously researched and specifically clinically proven Bacopa monnieri extract is arguably the most exciting addition to the Flordis range of practitioner prescribed natural medicines…

Read More